About Us
Medicine Beyond Borders
Dr. Ashleys Limited
Dr. Ashleys Limited, a global pharmaceutical company, develops, manufactures, and markets Active Pharmaceutical Ingredients (“API”) Orphan Drugs and provides Contract Research and Manufacturing Services (“CRAMS”) to other pharmaceutical companies. The company makes over 85 products focusing on Cancer medicine, Anti-malaria, HIV-AIDS medicine, COVID-19, and others. The company markets its product to over 80 countries via a network of over 100 distributors and 200 pharmaceutical companies in Europe, Africa, the Middle East, India, and Southeast Asia. Dr Ashley was founded in 2012 with the promise of delivering life-saving drugs to hard-to-reach places while remaining profitable.
Oncology (Cancer)
Hormonal Therapies
Antibiotics (Bacterial Infections)
Cardiovascular Diseases
Neurological Disorders
Antiviral Treatments
At Dr. Ashleys, our diverse, multilingual team leverages global cultural insights to foster innovation and inclusivity, enhancing client connections with empathy and understanding.
Locations
EU – Riga Latvia
Office Address
Aptiekas iela 7, Riga LV 1005 Latvija
Email Address
Phone Number
USA – Austin TX
Office Address
111 Congress Avenue, Suite 500, Austin, Texas 78701
Email Address
Phone Number
Hong Kong
Office Address
Unit No 1504, 15th Floor Peninsula Square, 18 Sung On Street, Hung Hom Kowloon Hong Kong Sar
Email Address
Phone Number
Cayman Islands
Office Address
4th Floor, Harbour Place, 103 South Church Street, P.O. Box 10240, Grand Cayman KY1-1002, Cayman Islands.
Email Address
Phone Number
Dr Kanans Visvanats FRSC / Dr. Kanans
Recipient of the Albert Schweitzer Award in Medicine by The Albert Schweitzer Foundation
Growing up in India as a son of a successful pharmaceutical manufacturer, Dr. Kanans was destined to make his mark beyond his country to become a global manufacturer. After obtaining a degree in Chemical Engineering, Dr. Kanans began to redefine the industry’s manufacturing processes for generic and patented drugs to reduce manufacturing costs and delivery systems. His first breakthrough was lowering the manufacturing cost for the treatment of Malaria. Because of his patented manufacturing, he is responsible for the low-cost distribution of millions of doses throughout third world countries and other critical Malaria hot spots.
